Sunniva has announced that Dave Lyle, Chief Financial Officer has resigned as an officer, effective November 1st, for personal reasons.
The Company's Global Controller, David Weinmann, has been appointed to Interim CFO. "Mr. Weinmann has a Bachelor of Science in Accountancy from San Diego State University," the team with the company explains. "David has over 20 years of progressively increasing experience in both public and privately held companies with the majority of his career in the biotech and pharmaceutical industries. Prior to joining Sunniva, he worked for Thermo Fisher Scientific, Inc., Accriva Diagnostics, and Ambit Biosciences. He has spent the past few years consulting for companies within the start up, transition, and transaction phase, this includes, ACEA Biosciences, Inc., Ametek, Inc., and Robo3D Limited."
"On behalf of the Board of Directors and our employees, I would like to thank Dave Lyle for his contributions to Sunniva," said CEO Anthony Holler. "David Weinmann has been an integral part of the building of the Finance group California and overseeing the development and implementation of the financial planning and accounting functions as we transitioned to the Carlsbad office. With Mr. Weinmann's outstanding leadership skills and his finance and accounting experience supported by the team Sunniva has built over the past six months we have every confidence in David's ability to succeed in this role."